These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9226562)

  • 1. Estimation of impurity profiles of drugs and related materials. Part 16: Identification of the side-products of the ethinylation step in the synthesis of contraceptive gestogens.
    Horváth P; Balogh G; Brlik J; Csehi A; Dravecz F; Halmos Z; Laukó A; Rényei M; Varga K; Görög S
    J Pharm Biomed Anal; 1997 Jun; 15(9-10):1343-9. PubMed ID: 9226562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of synthetic oestrogens and progestagens in oral contraceptives on bile lipid composition.
    Down RH; Whiting MJ; Watts JM; Jones W
    Gut; 1983 Mar; 24(3):253-9. PubMed ID: 6826111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing contraceptive steroids and doses.
    Briggs MH
    J Reprod Med; 1983 Jan; 28(1 Suppl):57-62. PubMed ID: 6834349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of impurity profiles of drugs and related materials. 12. Isolation and identification of an isomeric impurity in danazol.
    Balogh G; Csizér E; Ferenczy GG; Halmos Z; Herényi B; Horváth P; Laukó A; Görög S
    Pharm Res; 1995 Feb; 12(2):295-8. PubMed ID: 7784348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desogestrel, norgestimate, and gestodene: the newer progestins.
    Kaplan B
    Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of steroids. XXXVIII. The use of high-performance liquid chromatography with diode-array UV detection for estimating impurity profiles of steroid drugs.
    Görög S; Herényi B
    J Chromatogr; 1987 Jul; 400():177-86. PubMed ID: 3667745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification of some human metabolites of norgestrel, a new progestational agent.
    DeJongh DC; Hribar JD; Littleton P; Fotherby K; Rees RW; Shrader S; Foell TJ; Smith H
    Steroids; 1968 May; 11(5):649-66. PubMed ID: 5650691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of impurity profiles of drugs and related materials: part 19: theme with variations. Identification of impurities in 3-oxosteroids.
    Görög S; Babják M; Balogh G; Brlik J; Dravecz F; Gazdag M; Horváth P; Laukó A; Varga K
    J Pharm Biomed Anal; 1998 Dec; 18(4-5):511-25. PubMed ID: 9919951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New progestogens in oral contraceptives.
    Runnebaum B; Rabe T
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1059-63. PubMed ID: 2960242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of contraceptive steroids on creatine kinase activity in serum.
    Gupta U; Gupta RC
    Clin Chem; 1982 Jun; 28(6):1402-3. PubMed ID: 7074957
    [No Abstract]   [Full Text] [Related]  

  • 15. A norgestimate-containing oral contraceptive: review of clinical studies.
    Kafrissen ME
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1196-202. PubMed ID: 1415446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate.
    Corson SL
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1556-61. PubMed ID: 8178906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of impurity profiles of drugs and related materials: part XXI. HPLC/UV/MS study of the impurity profile of ethynodiol diacetate.
    Babják M; Balogh G; Gazdag M; Görög S
    J Pharm Biomed Anal; 2002 Aug; 29(6):1153-7. PubMed ID: 12110402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women.
    Nilsson S; Nygren KG; Johansson ED
    Am J Obstet Gynecol; 1977 Sep; 129(2):178-84. PubMed ID: 900181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matrices.
    Görög S; Bihari M; Csizér E; Dravetz F; Gazdag M; Herényi B
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):85-92. PubMed ID: 8833970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological and histochemical changes in the cervix uteri under contraceptive pills.
    El Hakim SM; Abdin FH; Kandil O
    Egypt Popul Fam Plann Rev; 1976 Dec; 10(2):20-33. PubMed ID: 12308408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.